Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)
This study is currently recruiting participants.
Verified March 2012
by Dong-A Pharmaceutical Co., Ltd.
Study NCT01553721 Information provided by Dong-A Pharmaceutical Co., Ltd.
First Received on January 1, 2012. Last Updated on March 12, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pulmonary Arterial Hypertension
Additional conditions recognized in this trial
More general conditions related to this trial
Respiratory Tract Diseases
Interventions listed in this trial
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Phosphodiesterase 5 Inhibitors
Sponsors listed in this trial
Dong-A Pharmaceutical Co., Ltd.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers